În afara temei aiqbench
Această știre a fost preluată de la o sursă pe care o urmărim, dar nu ține de domeniul AI sau cuantic, așa că nu există o perspectivă aiqbench pentru ea.
Montana’s plan to become an experimental medical hub just pushed forward
As of this week in Montana, any biotech company with an experimental drug has a clear path to selling it to consumers. Companies whose drugs have been through preliminary testing—sometimes in as few as 10 healthy people—can pay $12,500 to apply to a newly established review board for approval. Once its treatment is rubber-stamped, the…
Citește articolul complet pe MIT Technology ReviewSubiecte conexe
Digital States 2026: AI Moves From Experiment to Infrastructure
govtech.com · 24 sept. 2026
[AINews] Reality Checks on AI News (Yegge shuts down Gas Town, Databricks’ +60% Astra cost)
Latent Space · 17 sept. 2026
News Archive 2026
Quantum Computing Report · 25 iul. 2026
The Download: Montana’s new experimental drug rules
MIT Technology Review · 31 iul. 2026